Related by context. All words. (Click for frequent words.) 81 postintervention 71 nondiabetic patients 70 % CI #.#-#.# [003] 69 PASI scores 69 perioperative mortality 69 posttreatment 69 underwent CABG 68 lopinavir r arm 67 underwent resection 67 % CI #.#-#.# [007] 67 biochemical relapse 67 Complication rates 67 posttransplant 67 postoperative mortality 67 % CI #.#-#.# [008] 67 Baseline characteristics 67 pancreatic resection 67 interquartile range 66 postoperative morbidity 66 SGRQ 66 CCyR 66 CR nPR 66 mL/min/#.# m 2 66 p = NS 66 postoperative complication 66 multivariable analyzes 66 Operative mortality 66 NNT = 66 HbA 1c levels 66 MMSE scores 66 postprocedure 66 definite stent thrombosis 66 achieved CCyR 66 inhospital 66 hepatorenal syndrome 65 asymptomatic carotid stenosis 65 low dose Iluvien 65 hsCRP levels 65 amoxicillin clavulanate 65 mcg albinterferon alfa 2b 65 NMIBC 65 postdischarge 65 prospectively stratified 65 HBeAg seroconversion 65 Fasting blood glucose 65 plasma creatinine 65 nonoperative 65 hours postdose 65 serum aminotransferase levels 65 PSA nadir 65 hepatic resection 65 deep venous thromboses 65 diagnostic angiography 65 HbA1C levels 65 placebo dexamethasone 65 intraobserver 65 PREZISTA ritonavir 65 QTcF 65 nadroparin 65 alanine aminotransferase ALT 65 aspartate aminotransferase AST 65 asthma exacerbation 65 glycated hemoglobin levels 65 Postoperatively 65 REYATAZ r arm 65 hemoglobin A1c levels 65 corticosteroid dose 65 comparator arm 64 echocardiographic parameters 64 MACCE 64 EDSS scores 64 advanced adenoma 64 antiretroviral naïve 64 -#.# log# 64 nicardipine 64 hepatectomy 64 neurologic outcomes 64 urinary N telopeptide 64 angiographic outcomes 64 P = .# 64 unstable angina pectoris 64 glomerular filtration 64 hip BMD 64 serum phosphate 64 coronary revascularization 64 calculated creatinine clearance 64 intravenous diuretics 64 p = .# [002] 64 HSCT 64 underwent surgical resection 64 postoperative bleeding 64 DAS# CRP 64 underwent coronary angiography 64 primary patency 64 morphometric vertebral fractures 64 Erectile function 64 relapsed MM 64 mcg QD 64 oncologic outcomes 64 Index CDAI 64 aldosterone antagonist 64 oxygen desaturation 64 postoperative AF 64 PCWP 64 elevated ALT 64 genotypic resistance 64 advanced neoplasia 64 oxycodone CR 64 subtrochanteric 64 ALT elevation 64 NIHSS score 64 TURBT 64 severe exacerbations 64 retrospective cohort 64 undergone radical prostatectomy 64 nmol l 63 Taxus Stent 63 refractory ischemia 63 NATRECOR R 63 arterial oxygen saturation 63 psychiatric comorbidities 63 timepoints 63 nonfatal MI 63 postop 63 radical nephrectomy 63 underwent percutaneous coronary 63 femoral neck fracture 63 Univariate 63 confirmed CCyR 63 HER2 expression 63 postoperative chemotherapy 63 achieved ACR# 63 estimated glomerular filtration 63 IOP lowering 63 FluCAM arm 63 biochemical recurrence 63 ELBW infants 63 MADRS score 63 Crohn Disease Activity 63 preoperative PSA 63 PSADT 63 multivariable analysis 63 periprocedural 63 thoracoscopic lobectomy 63 lumbar spine BMD 63 adenotonsillectomy 63 specific antigen PSA 63 underwent liver transplantation 63 glycosylated hemoglobin HbA1c 63 arterial thromboembolic events 63 alanine aminotransferase 63 androgen suppression 63 colorectal adenoma 63 postoperative complications 63 spirometric 63 Scale EDSS 63 noncardiac 63 Pharmacokinetic parameters 63 HBeAg negative patients 63 VaD 63 reinfarction 63 univariate analysis 63 mm Hg diastolic 63 CI -#.# 63 pCR 63 radical retropubic prostatectomy 63 glycated hemoglobin HbA1c 63 postoperative pulmonary 63 PREZISTA r arm 63 Arch Intern Med 63 overt nephropathy 63 mL/min/#.# m2 63 dalteparin 63 unfractionated heparin UFH 63 sociodemographic factors 63 CrCl 63 CI #.#-#.# [001] 63 Platelet counts 63 progression TTP 63 Stent thrombosis 63 leukocyte count 63 primary percutaneous coronary 62 HbA1c levels 62 % Confidence Interval 62 reintubation 62 perioperative complications 62 % CI #.#-#.# [006] 62 Postoperative complications 62 MMSE score 62 symptomatic carotid stenosis 62 intraoperative complications 62 -#.# log# copies mL 62 sociodemographic characteristics 62 RYGB 62 p = #.# [003] 62 Brief Psychiatric 62 multivariable adjusted 62 Flu Cy 62 postdose 62 FOLFOX4 62 subcutaneous enoxaparin 62 nonfasting triglyceride levels 62 serum phosphorous 62 EDSS score 62 nonobese 62 mg/m2 dose 62 laparoscopically assisted 62 Kaplan Meier analysis 62 ALT flares 62 postinjury 62 paclitaxel eluting stents 62 TAXUS Express Stent 62 dexmedetomidine 62 multivariate analyzes 62 recurrent VTE 62 ipsilateral stroke 62 liver resection 62 confidence interval CI 62 #.#/#.# mmHg [001] 62 Index CDAI score 62 Primary endpoints 62 serum estradiol 62 MIRP 62 virologic failure 62 tipranavir r 62 baseline LDH 62 microalbumin test 62 NATRECOR ® 62 recurrent venous thromboembolism 62 HBeAg positive patients 62 CYPHER Stent 62 perioperatively 62 revascularizations 62 serum lipid levels 62 endoscopic remission 62 pulmonary capillary wedge 62 antiretroviral naive 62 #q# deletion syndrome 62 intact parathyroid hormone 62 ejection fractions 62 renal biopsy 62 interferon ribavirin 62 CI #.#-#.# [002] 62 COPD exacerbation 62 liver biopsies 62 binary restenosis 62 treated nonsurgically 62 lactate dehydrogenase 62 DAS# remission 62 graft occlusion 62 Secondary efficacy endpoints 62 atherosclerotic renal artery stenosis 62 pegylated interferon alfa 2b 62 NHANES III 62 cardiac perfusion 62 TMP SMX 62 advanced adenomas 62 aneurysmal subarachnoid hemorrhage 62 posttest 62 confidence interval #.#-#.# 62 mIU ml 62 pT3 62 thrombocytopenic 62 neurodevelopmental impairment 62 TKAs 62 elevated LDH 62 prospectively defined 62 repeat revascularization 62 pathologic fractures 62 pulsatile flow 62 invasive angiography 62 Kaplan Meier estimates 62 serum urate 62 left ventricular systolic 62 neurocognitive function 62 Preoperatively 62 postmenopausal osteoporotic women 62 rFSH 62 KRAS mutations occur 62 aminotransferases 62 systemic corticosteroids 62 #.#mg/dL 62 abacavir lamivudine 62 Postoperative 62 ADCS CGIC 62 anemia hemoglobin 61 DES implantation 61 hip resurfacing arthroplasty 61 perinatal outcomes 61 serum IGF 61 atherogenic dyslipidemia 61 interobserver reliability 61 Coronary artery bypass graft 61 OPCAB 61 sd = 61 unresectable HCC 61 placebo fluoxetine 61 undetectable HBV DNA 61 mL kg 61 IBDQ 61 LV dysfunction 61 stage IIIb IV 61 Apgar scores 61 PRADAXA #mg 61 umol L 61 percutaneous drainage 61 radical cystectomy 61 β blockers 61 carotid artery stenting CAS 61 baseline Hb 61 HOMA IR 61 NPH insulin 61 XIENCE V demonstrated 61 serum clusterin levels 61 neutrophil counts 61 fasting plasma glucose FPG 61 myocardial viability 61 carotid stenosis 61 hemoglobin A1c HbA1c 61 insulin detemir 61 calcaneal fractures 61 inhospital mortality 61 chorioamnionitis 61 affective psychosis 61 locoregional 61 HIV HCV coinfected 61 CABG surgeries 61 lowest tertile 61 IFN alfa 61 PLX STROKE targeting 61 liver histology 61 clinically localized prostate 61 moderate renal impairment 61 ratio ICER 61 sonographic examinations 61 N telopeptide 61 nondepressed 61 lymphocyte count 61 euthyroid 61 plasma cortisol 61 Folfox 61 naïve HCV 61 lymphocytosis 61 percutaneous intervention 61 haematologic 61 mean ± SEM 61 hypophosphatemia 61 #mmHg [001] 61 highest tertile 61 lispro 61 recurrent glioblastoma multiforme 61 peak VO2 61 femoral shaft fracture 61 CDAI score 61 invasive aspergillosis 61 tirofiban 61 hemoglobin concentrations 61 pulmonary artery banding 61 #mg/day [001] 61 F FDG PET 61 de novo AML 61 -#.# ± [002] 61 postoperative infections 61 depressive symptomatology 61 serum urate levels 61 crossclamp 61 #mg q8h 61 Coronary artery bypass grafting 61 Secondary endpoints include 61 Radical prostatectomy 61 retrospectively analyzed 61 Non inferiority 61 antithymocyte globulin 61 complete cytogenetic response 61 Montgomery Asberg Depression 61 liver transplant recipients 61 annualized relapse 61 elective PCI 61 systolic dysfunction 61 virological response 61 femoral neck fractures 61 IRLS score 61 Patency 61 IR Cysteamine 61 comorbid conditions 61 creatinine levels 61 subthreshold depression 61 octreotide LAR 61 undergoing coronary angiography 61 hemodynamically significant 61 atrioventricular block 61 Median survival 61 ertapenem 61 estimated GFR 61 nonobstructive CAD 61 lamivudine monotherapy 61 QRS duration 61 preoperative chemotherapy 61 timepoint 61 mg TID 61 seroprotection 61 revascularization procedure 61 hemodynamic parameters 61 median PFS 61 silent ischemia 61 azoospermia 61 baseline HbA1c 61 normotensive 61 resected pancreatic cancer 61 pamidronate 61 ICD implantation 61 hemostatic efficacy 61 endometrial carcinoma 61 Secondary endpoints 61 desvenlafaxine succinate 61 intima media thickness 61 cTnI 61 lymphadenectomy 61 ER CHOP 61 ischemia driven 61 pulmonary dysfunction 61 clinicopathological features 60 XIENCE V PROMUS Stent 60 total abdominal hysterectomy 60 symptomatic VTE 60 Skin sterol 60 diameter stenosis 60 chemoradiation therapy 60 alfuzosin 60 mediastinitis 60 nonoperative treatment 60 NSTEMI 60 radiographic outcomes 60 Injury Severity Score 60 μmol L 60 statistical significance p 60 postoperative atrial fibrillation 60 NIHSS 60 electrophysiologic 60 multivariate logistic regression 60 pericardial effusion 60 gestational hypertension 60 fibrinolysis 60 Charlson comorbidity index 60 patients undergoing CABG 60 prospective observational studies 60 preoperative intraoperative 60 antibody titer 60 SGPT 60 p ≤ 60 mmHg diastolic 60 #mg BID [001] 60 multivariate Cox 60 bronchoalveolar lavage 60 myocardial infarction ventricular fibrillation 60 CPAP adherence 60 parous women 60 Lumbar spine 60 baseline FEV 60 PREZISTA r 60 HBeAg 60 normothermic 60 recurrent atrial fibrillation 60 nonobese patients 60 prognostic variables 60 cerebral oxygenation 60 perioperative morbidity 60 CHD CVD 60 CIMZIA ™ 60 Kaplan Meier 60 angioplasty stenting 60 ximelagatran 60 AST ALT 60 CANCIDAS 60 nodular partial response 60 Breslow thickness 60 BMI z 60 mean baseline A1C 60 % CI #.#-#.# [005] 60 confidence intervals CIs 60 radiochemotherapy 60 intermittent dosing 60 NYHA functional class 60 carotid IMT 60 detectable HCV RNA 60 Ejection Fraction 60 vertebral fracture 60 prospectively evaluated 60 receiving prophylactic anticoagulation 60 RVOT 60 prespecified secondary 60 Infusion Reactions Severe 60 serum creatinine levels 60 cerebrovascular events 60 #.#ng/ml 60 Kaplan Meier estimate 60 coronary revascularization procedures 60 Coronary Artery Bypass Graft 60 APTIVUS r 60 lung resections 60 TEAEs 60 thyrotropin levels 60 obstructive coronary artery 60 IELT 60 pretest probability 60 nephron sparing surgery 60 vaginal hysterectomy 60 oxycodone IR 60 HBV DNA levels 60 glomerular filtration rate 60 LVEF 60 HAQ DI 60 atazanavir ritonavir 60 arteriography 60 Zometa hazard 60 exploratory endpoints 60 cytoreductive surgery 60 aged ≥ 60 neurodevelopmental outcomes 60 patients undergoing noncardiac 60 radiotherapy RT 60 serum potassium 60 mm ³ 60 leucopenia 60 venous thromboembolic disease 60 Hb A1C 60 HDRS 60 pmol L 60 highly emetogenic 60 undergoing CABG 60 pretransplant 60 evaluable subjects 60 adenoma recurrence 60 sociodemographic variables 60 extubation 60 coronary calcification 60 pyelonephritis 60 plasma uric acid 60 nonfatal myocardial infarction MI 60 coronary angiograms 60 seropositivity 60 parathyroidectomy 60 receiving VICTRELIS 60 Fasting plasma glucose 60 mcg BID 60 Tasigna prolongs 60 exhaled NO 60 lipid lowering agents 60 ACTEMRA TM 60 symptomatic intracerebral hemorrhage 60 transrectal ultrasound guided 60 noncardiovascular mortality 60 response CCyR 60 #mg dose [002] 60 BRCA2 mutation carriers 60 Hemodynamic 60 aspartate aminotransferase 60 urinary albumin 60 tibiofemoral 60 rimonabant #mg 60 blastic phase 60 VAD implantation 60 mechanically ventilated patients 60 flutamide 60 μg L 60 intravesical therapy 60 plain radiographs 60 CP CPPS 60 beta blocker therapy 60 everolimus eluting stents 60 microbiologically evaluable 60 adenoidectomy 60 empyema 60 activated partial thromboplastin 60 peginterferon alfa 2a 60 nonvertebral fracture 60 conventional angiography 60 placebo PBO 60 obstructive CAD 60 undergoing radical prostatectomy 60 CDAI 60 serum concentrations 60 prospective multicenter study 60 tertiles 60 SUVmax 60 salpingo oophorectomy 60 adnexal mass 60 microalbumin 60 treated nonoperatively 60 thromboprophylaxis 60 serum magnesium 60 preterm newborns 60 UPDRS motor 60 neurologic complications 60 p = ns 60 multiple logistic regression 60 fibrinolytic therapy 60 nondiabetic 60 distal radial fractures 60 platelet reactivity 60 antibiotic regimens 60 TLUS 60 overnight polysomnography 60 virologic response 60 esophageal resection 60 paroxysmal AF 60 R0 resection 60 comorbid illnesses 60 clinico pathological 60 univariate 60 ng dL 60 ejection fraction EF 60 colorectal liver metastases 60 experienced virologic failure 60 clodronate 60 angiographically 60 hyperphenylalaninemia HPA due 60 Viral load 60 hemodialysis patients 60 CORE OM 60 pg mL 60 procedural sedation 59 nodal metastases 59 oral hypoglycemic agent 59 allogeneic HSCT 59 CIMZIA TM certolizumab pegol 59 Montgomery Åsberg Depression 59 diastolic blood pressures 59 tobramycin inhalation solution 59 angiographic restenosis 59 percutaneous vertebroplasty 59 elevated IOP 59 hypoglycemic events 59 Kaplan Meier survival 59 cytogenic 59 hemodynamically unstable 59 renal cell carcinomas 59 neurologic progression 59 cranial irradiation 59 Subgroup analysis 59 recurrent DVT 59 adnexal masses 59 DAS# scores 59 GnRH agonist 59 acetabular fractures 59 upper endoscopy 59 -#.# mg dL [001] 59 postoperative infection 59 ADCS ADL 59 Doxil ® 59 radical prostatectomy RP 59 NSTE ACS 59 acute aortic dissection 59 meta regression 59 TMC# r 59 ug dose 59 PaO 2 59 anthracycline taxane 59 autonomic dysfunction 59 troponin T 59 mm Stent 59 fraction LVEF 59 Hb A1c 59 PERMP 59 mg kg dose 59 CK MB 59 Events MACE 59 elevated serum creatinine 59 mg administered orally 59 intravascular hemolysis 59 Cystatin C 59 urine albumin 59 intracranial hemorrhage ICH 59 Poisson regression 59 cerebrovascular accidents 59 Exclusion criteria 59 KRAS mutant tumors 59 pelvic lymphadenectomy 59 MitraClip device 59 SLNB 59 glycosylated hemoglobin levels 59 pharmacodynamic parameters 59 stent binary restenosis 59 urolithiasis 59 colectomy 59 Am J Cardiol 59 Subgroup analyzes 59 decompensated cirrhosis 59 preeclamptic 59 iPTH 59 lumbar disc herniation 59 albumin excretion rate 59 Y BOCS 59 GERD symptom 59 titrated glipizide 59 tolterodine ER 59 serum PSA 59 nonpregnant women 59 HRQoL 59 certolizumab 59 prostate cancer CaP 59 sUA 59 OGTT 59 autologous SCT 59 symptomatic intracranial 59 IQR 59 sleeve lobectomy 59 VT VF 59 Renal Cell Carcinoma RCC 59 #Gy 59 hyperacute 59 brachial artery flow 59 DCCT 59 methacholine challenge 59 dimensional echocardiography 59 Ishak fibrosis score 59 recurrent UTI 59 cGy 59 odds ratios ORs 59 asystole 59 urate lowering therapy 59 cytoreduction 59 malignant neoplasm 59 revascularization procedures 59 mEq L 59 postoperative radiographs 59 thromboses 59 abnormal p# biomarker 59 symptomatic aortic stenosis 59 steroid dexamethasone 59 mg simvastatin 59 chlorambucil 59 ARB telmisartan 59 allogeneic hematopoietic stem cell 59 cerebral angiography 59 underwent radical prostatectomy 59 reinterventions 59 IIIa inhibitors 59 Median PFS 59 Carotid Revascularization Endarterectomy vs. 59 clinically meaningful improvement 59 ACR Pedi 59 mg BID dose 59 NAMCS 59 MELD scores 59 coinfected patients 59 CC genotype 59 STRIDE PD 59 isolated systolic hypertension 59 plus dexamethasone 59 upper gastrointestinal bleeding 59 GH deficiency 59 tissue oxygenation 59 neurodevelopmental outcome 59 venlafaxine XR 59 6MWD 59 hematologic parameters 59 nulliparous women 59 LNG IUS 59 mg kg Hematide 59 receiving Vectibix monotherapy 59 STN stimulation 59 abdominal hysterectomy 59 tumor histology 59 visceral metastases 59 rebleeding 59 FFR guided 59 SCr 59 ultrasonographic 59 peripheral arterial occlusive disease 59 undergoing tonsillectomy 59 intravitreal injections 59 imipenem 59 retinal thickness 59 Nebulized 59 HbA 1c 59 CHD mortality 59 TAXUS VI 59 microbiological eradication 59 fasting insulin 59 cilostazol 59 infliximab monotherapy 59 total thyroidectomy 59 interrater reliability 59 mild renal insufficiency 59 transvaginal sonography 59 8mg/kg 59 elevated troponin 59 Coronary artery bypass 59 foveal thickness 59 preop 59 μg dL 59 ovarian malignancy 59 poststroke 59 oral anticoagulation 59 UPPP 59 radioiodine therapy 59 ‰ ¥ 59 upper endoscopies 59 secondary efficacy endpoint 59 oral allopurinol 59 ALND 59 + PH# 59 extracolonic findings 59 dosing cohorts 59 APACHE II 59 venous thrombosis 59 adjunctive placebo 59 CIN2 + 59 tapentadol ER 59 hippocampal volumes 59 PPCM 59 serum uric acid 59 adrenalectomy 59 HRQL 59 corrected QT interval 59 intrapartum 59 invasive carcinomas 59 hypofractionated radiation 59 mg QD 59 RECORD1 59 transesophageal echocardiography 59 HF hospitalization 59 acute gout flares 59 gm dl 59 reoperations 59 prior nephrectomy 59 histological subtype 59 underwent angiography 59 observational cohort 59 FDA defined valvulopathy 59 symptomatic hyponatremia 59 underwent bariatric surgery 59 mediated dilation 59 pmol liter 59 DLQI 59 differentiate squamous 58 tapentadol IR 58 transcranial Doppler 58 nontraumatic 58 g dl 58 HCV RESPOND 2 58 severe neutropenia 58 NNRTI resistance 58 colon resection 58 dacarbazine chemotherapy 58 bilateral oophorectomy 58 ARCALYST ® 58 BENICAR HCT 58 transurethral resection 58 variceal bleeding 58 attain statistical significance 58 ARCOXIA 58 CK # plasma 58 duplex ultrasonography 58 ischemic lesions 58 debulking surgery 58 4mg/kg 58 HoLEP 58 FFNS 58 endocrinologic 58 cytologic 58 bortezomib refractory 58 myocardial infarction MI 58 lung resection 58 cerebral vasospasm 58 ADAS cog 58 hematologic toxicity 58 hepatic arterial 58 Erythropoietic therapies may 58 nucleoside naive 58 sirolimus stent 58 esophageal manometry 58 coronary arteriography 58 coronary stenosis 58 HIV seronegative 58 plus prednisone 58 reintervention 58 Decompensated Heart Failure 58 procalcitonin 58 Febrile neutropenia 58 systemic corticosteroid 58 bronchial hyperresponsiveness 58 myocardial reperfusion 58 metastatic GIST 58 epoetin alpha 58 urethral stricture 58 severe renal impairment 58 aminotransferase elevations greater 58 cEVR 58 hematopoietic cancers 58 bronchopulmonary dysplasia BPD 58 A1c levels 58 HBsAg 58 Meta analyzes 58 WOMAC pain 58 noninvasive outpatient 58 methotrexate therapy 58 Virologic 58 oblimersen 58 GOUT 58 LVSD 58 Median progression 58 subclinical hypothyroidism 58 ß blockers 58 Preoperative 58 EuroSCORE 58 active comparator 58 undetectable viral 58 left ventricular diastolic 58 serum sodium concentration 58 tracheal intubation 58 pulmonary angiography 58 mIU L 58 preoperatively 58 conditional logistic regression 58 bronchopulmonary dysplasia 58 3mg/kg 58 acute cholecystitis 58 lispro alone 58 osteoporotic vertebral compression fractures 58 moderately emetogenic 58 statistically significant p = 58 â ‰ ¥ 58 clevidipine 58 metastatic lung cancer 58 ALT normalization 58 transaminase levels 58 serum cortisol 58 urine NGAL 58 Engerix B 58 VLBW 58 Echocardiographic 58 tumor progression TTP 58 chronic hemodialysis 58 serum homocysteine 58 lumbar disk herniation 58 dose escalation phase 58 Secondary endpoints included 58 androgen deprivation 58 vitamin B# folic acid 58 carotid intima media 58 pre eclamptic 58 salmeterol fluticasone 58 ejaculatory function 58 tuberculin skin testing 58 multivariable logistic regression 58 Rating Scale MADRS 58 intravenous cyclophosphamide 58 zoledronate 58 dose statin therapy 58 ACUITY trial 58 mg ustekinumab 58 perinatal complications 58 ug kg 58 percutaneous transluminal coronary angioplasty 58 mild renal impairment 58 reduce serum phosphate 58 IPAH 58 q#h 58 Severity Index PASI 58 total hip arthroplasties 58 mm Hg systolic 58 ID TLR 58 anastomotic leak 58 nonvertebral 58 methotrexate monotherapy 58 carotid surgery 58 hypoperfusion 58 remission CR 58 argatroban 58 ruptured aneurysms 58 abnormal cytology 58 femoral neck BMD 58 cardiopulmonary bypass CPB 58 echocardiographic 58 cytoreductive nephrectomy 58 AGILECT R 58 Partial Response 58 neostigmine 58 glycated hemoglobin 58 mmHg systolic 58 pancreatectomy 58 mesalamine granules 58 BCG vaccinated 58 Thrombolysis 58 NAVISTAR R 58 Insulin sensitivity 58 LEXIVA r 58 aminotransferase ALT 58 QTc intervals 58 autologous chondrocyte implantation 58 Cardiopulmonary bypass 58 recurrent ischemic stroke 58 Logistic regression 58 % CI #.#-#.# [002] 58 pulmonary exacerbation 58 acromegalic patients 58 retrospectively reviewed